These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26713063)

  • 21. [Effect of medicinal treatment on epithelial wound healing after phacoemulsification].
    Tomilova EV; Nemsitsveridze MN; Panova IE
    Vestn Oftalmol; 2017; 133(3):44-50. PubMed ID: 28745656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures.
    Kinnunen K; Kauppinen A; Piippo N; Koistinen A; Toropainen E; Kaarniranta K
    Exp Eye Res; 2014 Mar; 120():82-9. PubMed ID: 24462278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
    Kim YH; Jung JC; Jung SY; Yu S; Lee KW; Park YJ
    Cornea; 2016 Feb; 35(2):234-42. PubMed ID: 26619385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
    Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H
    Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.
    Liu C; Liu Y; Ye S; Liu L; Zhang W; Wu M
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):831-6. PubMed ID: 25230350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.
    Wang C; Cao Y; Chen X; Cai M; Huang W
    Medicine (Baltimore); 2020 Dec; 99(49):e23131. PubMed ID: 33285687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium.
    Fukuda M; Kiyoi T; Takeda S; Sasaki Y; Masuoka T; Kubo E; Sasaki H
    J Ocul Pharmacol Ther; 2024 Sep; 40(7):428-434. PubMed ID: 39293057
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
    Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
    Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic comparisons of bromfenac in DuraSite and Xibrom.
    Si EC; Bowman LM; Hosseini K
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):61-6. PubMed ID: 21332395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical NSAIDs effect on corneal sensitivity.
    Singer DD; Kennedy J; Wittpenn JR
    Cornea; 2015 May; 34(5):541-3. PubMed ID: 25826326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
    Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.
    Gaynes BI; Fiscella R
    Drug Saf; 2002; 25(4):233-50. PubMed ID: 11994027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute corneal melt associated with topical bromfenac use.
    Prasher P
    Eye Contact Lens; 2012 Jul; 38(4):260-2. PubMed ID: 22169877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VITREOUS PROSTAGLANDIN E2 CHANGES AFTER TOPICAL ADMINISTRATION OF DICLOFENAC 0.1%, INDOMETHACIN 0.5%, NEPAFENAC 0.3%, AND BROMFENAC 0.09.
    Pastore MR; De Giacinto C; Cirigliano G; D'Aloisio R; Addobbati R; Agostinis C; Radillo O; Di Martino G; Di Nicola M; Cecchini P; Tognetto D
    Retina; 2020 Sep; 40(9):1838-1845. PubMed ID: 31800462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
    Donnenfeld ED; Donnenfeld A
    Int Ophthalmol Clin; 2006; 46(4):21-40. PubMed ID: 17060789
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
    Uchio E; Itoh Y; Kadonosono K
    Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits.
    Kida T; Kozai S; Takahashi H; Isaka M; Tokushige H; Sakamoto T
    PLoS One; 2014; 9(5):e96481. PubMed ID: 24796327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of textured eye drop bottles on the photostability of pranoprofen 0.1% ophthalmic solution.
    Iwatsuka K; Inada K; Ueoka H; Otsuka T; Maeda M; Yamaguchi M; Yasueda S
    Drug Dev Ind Pharm; 2015; 41(9):1526-31. PubMed ID: 25308744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.